5. American Thoracic Society. Dyspnea. Mechanisms,assessment,and management:a consensus statement. Am J Respir Crit Care Med,1999,159:321-340.
[2]
6. Nguyen HQ,Altinger J,Carrieri-Kohlman V,et al. Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease. J Pain Symptom Manage,2003,25:118-127.
[3]
7. Hajiro T,Nishimura K,Tsukino M,et al. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,1998,158:1185-1189.
[4]
8. Mahler DA,Harver A. A factor analysis of dyspnea ratings,respiratory muscle strength,and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis,1992,145(2 Pt 1):467-470.
10. Elías Hernández MT,Ortega Ruiz F,Sánchez Riera H,et al. Role of dyspnea in quality of life of the patient with chronic obstructive pulmonary disease. Arch Bronconeumol,1999,35:261-266.
3. GOLD Executive Committee. Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease. (Revised 2011). www.goldcopd.com.
[10]
4. Mahler DA,Wells CK. Evaluation of clinical methods for rating dyspnea. Chest,1988,93:580-586.
[11]
11. Mahler DA,Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest,1995,107:1585-1589.
